Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Part I. Pathology.
1. Lung pathology in connective tissue diseases (D. Tansey, A.G. Nicholson).
Part II. Radiologic investigations in connective tissue diseases.
2. High resolution computed tomography of the lungs (T. Franquet).
Part III. Pulmonary hypertension.
3. Pulmonary arterial hypertension in connective tissue disease (C. Denton, C. Black).
Part IV. Vasculitides.
4. Wegener's granulomatosus: a pulmonary perspective (P. Lamprecht, A. Schnabel, W.L. Gross).
5. Vasculitic syndromes other than Wegener's granulomatosus (A. Bennett, D. D'Cruz).
Part V. Pulmonary involvement in connective tissue disorders.
6. Lung disease in lupus (A. Kao, J. Sabatine, S. Manzi).
7. Pulmonary involvement in the anti-phospholipid syndrome (G. Espinosa et al.).
8. Rheumatoid arthritis and the lung (J. David, S. Edmonds).
9. Sjogren's syndrome and the lung (P. Papiris, H. Moutsopoulos).
10. Interstitial disease in systemic sclerosis (N. Goh, R. du Bois).
11. Pulmonary complications of polymyositis and dermatomyositis (J. Deng, M. Keane, J. Lynch III).
12. Pulmonary involvement in miscellaneous connective tissue diseases (A. Wells, G. Davies).
Part VI. Drug-induced respiratory disease.
13. Drug induced respiratory disease in connective tissue disease (P. Camus).
In this book is found the information essential to diagnosing, managing and treating the lung complications of connective tissue diseases. This is a notoriously difficult area, which continues to puzzle clinicians, despite the fact that these disorders are increasingly frequent (as a result of longer survival in connective tissue disease).
In separate chapters, the major connective tissue diseases are reviewed, with detailed discussion of a variety of lung abnormalities, including pleural disease, parenchymal lung disease and pulmonary vascular disease. There are also invaluable overviews of lung histological and CT appearances in these disorders, and a deeply insightful chapter on drug-induced lung disease in connective tissue disease. The emphasis in this book is on accuracy of evaluation and the construction of a logical management plan, based on disease severity and intrinsic progressiveness.
- No. of pages:
- © Elsevier Science 2004
- 1st September 2004
- Elsevier Science
- eBook ISBN:
- Paperback ISBN:
- Hardcover ISBN:
Killarney, Johannesburg, South Africa
Professor of Internal Medicine, University of Padova Medical School, Italy
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.